References
- Ashley AK, Kemp CJ. DNA-PK, ATM, and ATR: PIKKing on p53. Cell Cycle. 2018;17(3):275–276.
- Levine AJ. The many faces of p53: something for everyone. J Mol Cell Biol. 2019;11(7):524–530.
- Lane DP. Cancer. p53, guardian of the genome. Nature. 1992;358(6381):15–16.
- Wellenstein MD, Coffelt SB, Duits DEM, et al. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature. 2019;572(7770):538–542.
- Villanova T, Gesmundo I, Audrito V, et al. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Proc Natl Acad Sci U S A. 2019;116(6):2226–2231.
- Munoz-Moreno L, Carmena MJ, Schally AV, et al. Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists. Invest New Drugs. 2019. doi:10.1007/s10637-019-00831-2
- Barabutis N, Schally AV. Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines. Br J Cancer. 2008;98(11):1790–1796.
- Barabutis N, Schally AV. Growth hormone-releasing hormone: extrapituitary effects in physiology and pathology. Cell Cycle. 2010;9(20):4110–4116.
- Siejka A, Barabutis N, Schally AV. GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells. Cell Cycle. 2011;10(21):3714–3718.
- Barabutis N, Schally AV, Siejka A. P53, GHRH, inflammation and cancer. EBioMedicine. 2018;37:557–562.
- Zhang C, Cai R, Lazerson A, et al. Growth hormone-releasing hormone receptor antagonist modulates lung inflammation and fibrosis due to bleomycin. Lung. 2019;197(5):541–549.
- Uddin MA, Akhter MS, Singh SS, et al. GHRH antagonists support lung endothelial barrier function. Tissue Barriers. 2019;7:1669989.
- Kryeziu K, Bruun J, Guren TK, et al. Combination therapies with HSP90 inhibitors against colorectal cancer. Biochim Biophys Acta Rev Cancer. 2019;1871(2):240–247.
- Joshi AD, Dimitropoulou C, Thangjam G, et al. Heat shock protein 90 inhibitors prevent LPS-induced endothelial barrier dysfunction by disrupting RhoA signaling. Am J Respir Cell Mol Biol. 2014;50(1):170–179.
- Rafikov R, Dimitropoulou C, Aggarwal S, et al. Lipopolysaccharide-induced lung injury involves the nitration-mediated activation of RhoA. J Biol Chem. 2014;289(8):4710–4722.
- Barabutis N, Dimitropoulou C, Gregory B, et al. Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition. J Cell Mol Med. 2018;22(3):1792–1804.
- Uddin MA, Barabutis N. P53: the endothelium defender. J Cell Biochem. 2019;120:10952–10955.
- Barabutis N, Uddin MA, Catravas JD. Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation. Cytokine. 2019;113:427–432.
- Barabutis N, Dimitropoulou C, Birmpas C, et al. p53 protects against LPS-induced lung endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2015;308(8):L776–87.
- Uddin MA, Akhter MS, Siejka A, et al. P53 supports endothelial barrier function via APE1/Ref1 suppression. Immunobiology. 2019;224(4):532–538.
- Akhter MS, Uddin MA, Kubra K-T, et al. P53-induced reduction of lipid peroxidation supports brain microvascular endothelium integrity. J Pharmacol Sci. 2019;141:83–85.
- Zeeshan HM, Lee G, Kim H-R, et al. Endoplasmic reticulum stress and associated ROS. Int J Mol Sci. 2016;17(3):327.
- Barabutis N. Unfolded protein response in acute respiratory distress syndrome. Lung. 2019;197:827–828.
- Amen OM, Sarker SD, Ghildyal R, et al. Endoplasmic reticulum stress activates unfolded protein response signaling and mediates inflammation, obesity, and cardiac dysfunction: therapeutic and molecular approach. Front Pharmacol. 2019;10:977.
- Waldherr SM, Strovas TJ, Vadset TA, et al. Constitutive XBP-1s-mediated activation of the endoplasmic reticulum unfolded protein response protects against pathological tau. Nat Commun. 2019;10(1):4443.
- Smith JA. Regulation of cytokine production by the unfolded protein response; implications for infection and autoimmunity. Front Immunol. 2018;9:422.
- Barabutis N. Unfolded protein response supports endothelial barrier function. Biochimie. 2019;165:206–209.
- Akhter MS, Uddin MA, Barabutis N. Unfolded protein response regulates P53 expression in the pulmonary endothelium. J Biochem Mol Toxicol. 2019;33(10):e22380.